IL6 and juvenile idiopathic arthritis: In 4 children the anti-TNFα was changed due to disease relapse in peripheral joints or unsatisfactory treatment result of cervical inflammation; two of our refractory JIA patients received also anti-IL-6 therapy as specified in the Table 1.